Skip to main content
OpenTrials
Completed

NCT Number: NCT02728791

Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution

Correlation study between the data provided by two measurement systems, trans- pulmonary thermodilution and ClearSight © (non invasive), to determine the interest in routine use (cardiac output, cardiac index, stroke volume and blood pressure).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Shock Cardiac Output, Low Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU BREST, Hôpital de la Cavale Blanche

Brest, 29200, France

About this study

Since 2014, Edwards society has developed a completely non-invasive monitoring device for measurement of blood pressure and continuous cardiac output without inserting foreign intravascular bodies in the patient. Initially tested on healthy volunteers cardiac disease -free, the correlation with the other devices seems to be good. If this ClearSight © system show a relevant accuracy in measuring blood pressure and cardiac output with a specific ICU hospitalized population, it could justify its place in the therapeutic arsenal of monitoring in intensive care.

This is a common care ,prospective observational single center study , concerning the results of blood pressure , cardiac output values and their variations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age>18
  • hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs
  • No opposition formulated

Exclusion criteria

  • Impossibility of establishment of one of the cardiac output measurement devices
  • Pregnant woman
  • Refuse to participate

Treatment and study plan

Primary outcomes

  1. Comparison of values and changes in cardiac index between the two devices

    Time frame: 2 days

Secondary outcomes

  1. Comparison of values and variations in mean arterial pressure between the two devices

    Time frame: 2 days

  2. Comparison of values and variations in mean cardiac output between the two devices

    Time frame: 2 days

  3. Comparison of values and variations in mean stroke volume variation between the two devices

    Time frame: 2 days

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Comparaison de Mesure de débit Cardiaque Entre système Clearsight® et Thermodilution Transpulmonaire.

Acronym: CONDUCT

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Apr 5, 2016
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.